MedPath

Noninvasive Hemoglobin Repeatability and Reproducibility in a Blood Donation Setting

Not Applicable
Completed
Conditions
Healthy
Anemia
Interventions
Device: Rad-67 Pulse oximeter & DCI Mini sensor
Registration Number
NCT04490863
Lead Sponsor
Masimo Corporation
Brief Summary

The primary objective of this clinical investigation is to report on the repeatability and reproducibility of SpHb measurements from Rad-67 devices and DCI Mini sensors used to screen prospective blood donors at a donation center.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • At least 18 years of age
  • Weight at least 110 pounds
  • Subjects with the intention of being screened for eligibility to donate blood
  • The subject has given written informed consent to participate in the study
Exclusion Criteria
  • Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, infections, abnormalities, etc.
  • Subjects unwilling to remove nail polish or acrylic nails
  • Subjects with blood cancers such as leukemia
  • Subjects with hemoglobin disorders such as sickle-cell anemia and thalassemia or with known history of infectious diseases such as HIV/AIDS, syphilis, hepatitis, etc.
  • Subjects with self-disclosed/known pregnancy at the time of enrollment
  • Subjects deemed not suitable for the study at the discretion of the investigator
  • Subjects unlikely to be able to refrain from excessive motion during data collection. Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test subjectsRad-67 Pulse oximeter & DCI Mini sensorAll subjects are enrolled and receive Rad-67 Pulse oximeter \& DCI Mini sensor for measurement of hemoglobin.
Primary Outcome Measures
NameTimeMethod
Coefficient of Variation of Rad-67Approximately 90 minutes per subject

Coefficient of variation will be computed using Repeatability and Reproducibility variance.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Blood Bank - Site 1

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath